FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890174389> ?p ?o ?g. }

• W2890174389 abstract "11077 Background: Kaposi’s Sarcoma (KS) is a angioproliferative disease related to AIDS/HIV (AIDS-KS) or not (Classic, CKS). Treatment options are limited in low-income countries where taxanes represent a cost-effective alternative. Our aim was to compare overall response (ORR) of paclitaxel and progression free survival (PFS) and overall survival (OS) between KS subtypes. Methods: We reviewed 203 medical records from pts diagnosed between 2002-2014 at the Instituto Nacional de Enfermedades Neoplasicas (Peru). Survival differences were calculated by log-rank test in the univariate analysis and Cox regression analysis for prognostic factors. Results: From 203 pts, 85 had CKS and 118 AIDS-CK. Mean age was 67 and 36years in CKS and AIDS-KS, respectively. Most pts were males (84.7%), coinfections as tuberculosis (11.9%) were more frequent in AIDS-CK. In CKS pts, 80% debuted with localized elevated lesions at lower limbs, 16% were resected, 48% received RT and 29% paclitaxel. Among AIDS-KS, 37% had poor risk, 22% were diagnosed concurrently to HIV infection. 76.9% had generalized lesions with origin at lower limbs, 50.5% had +ve nodes and 19% visceral disease. 25.8% had Zubrod > 2 and mean neutrophil to lymphocyte ratio (NLR) was 3.5, CD4 count was lower in pts with recently diagnosis of AIDS/HIV (166 vs 268, p = 0.039) and no differences were noted on viral load (mean 233 411). 77.1% of AIDS-KS pts received ART and 56.8% paclitaxel. In AIDS-KS ORR was 77%(CR:52%, PR:22%) versus 86% in CKS (CR:43%, PR:43%). At 4.3year median follow-up, 3-year PFS and OS was 71% and 75% in AIDS-CK, while CKS had 78% and 79%, respectively. Paclitaxel was associated with better survival among AIDS-KS patients (PFS HR:0.41, 95%CI:0.2-0.7, p = 0.004 and OS HR: 0.37, 95%CI:0.1-0.7, p = 0.007), patients with Zubrod≤2 had more survival benefit. There was not survival benefit in CKS pts. At multivariate analysis, ART and paclitaxel were associated with favorable PFS and OS, while higher NLR and poorer status performance to worse outcomes in AIDS-KS pts. Conclusions: Paclitaxel is an effective alternative treatment for AIDS-KS, there was not survival benefit in CKS patients. Poorer status performance and higher NLR were associated to worse prognosis." @default.
• W2890174389 created "2018-09-27" @default.
• W2890174389 creator A5000668487 @default.
• W2890174389 creator A5017769557 @default.
• W2890174389 creator A5019169960 @default.
• W2890174389 creator A5019668781 @default.
• W2890174389 creator A5043643636 @default.
• W2890174389 creator A5052159944 @default.
• W2890174389 creator A5056734221 @default.
• W2890174389 creator A5066039599 @default.
• W2890174389 creator A5075689224 @default.
• W2890174389 creator A5082959086 @default.
• W2890174389 date "2017-05-20" @default.
• W2890174389 modified "2023-10-01" @default.
• W2890174389 title "When to treat Kaposi’s Sarcoma? Paclitaxel survival benefit on classic versus AIDS/HIV-related subtypes." @default.
• W2890174389 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.11077" @default.
• W2890174389 hasPublicationYear "2017" @default.
• W2890174389 type Work @default.
• W2890174389 sameAs 2890174389 @default.
• W2890174389 citedByCount "0" @default.
• W2890174389 crossrefType "journal-article" @default.
• W2890174389 hasAuthorship W2890174389A5000668487 @default.
• W2890174389 hasAuthorship W2890174389A5017769557 @default.
• W2890174389 hasAuthorship W2890174389A5019169960 @default.
• W2890174389 hasAuthorship W2890174389A5019668781 @default.
• W2890174389 hasAuthorship W2890174389A5043643636 @default.
• W2890174389 hasAuthorship W2890174389A5052159944 @default.
• W2890174389 hasAuthorship W2890174389A5056734221 @default.
• W2890174389 hasAuthorship W2890174389A5066039599 @default.
• W2890174389 hasAuthorship W2890174389A5075689224 @default.
• W2890174389 hasAuthorship W2890174389A5082959086 @default.
• W2890174389 hasConcept C121608353 @default.
• W2890174389 hasConcept C126322002 @default.
• W2890174389 hasConcept C142724271 @default.
• W2890174389 hasConcept C143998085 @default.
• W2890174389 hasConcept C159047783 @default.
• W2890174389 hasConcept C2777292972 @default.
• W2890174389 hasConcept C2778256501 @default.
• W2890174389 hasConcept C3013748606 @default.
• W2890174389 hasConcept C71924100 @default.
• W2890174389 hasConceptScore W2890174389C121608353 @default.
• W2890174389 hasConceptScore W2890174389C126322002 @default.
• W2890174389 hasConceptScore W2890174389C142724271 @default.
• W2890174389 hasConceptScore W2890174389C143998085 @default.
• W2890174389 hasConceptScore W2890174389C159047783 @default.
• W2890174389 hasConceptScore W2890174389C2777292972 @default.
• W2890174389 hasConceptScore W2890174389C2778256501 @default.
• W2890174389 hasConceptScore W2890174389C3013748606 @default.
• W2890174389 hasConceptScore W2890174389C71924100 @default.
• W2890174389 hasLocation W28901743891 @default.
• W2890174389 hasOpenAccess W2890174389 @default.
• W2890174389 hasPrimaryLocation W28901743891 @default.
• W2890174389 hasRelatedWork W176668128 @default.
• W2890174389 hasRelatedWork W178089672 @default.
• W2890174389 hasRelatedWork W1968742878 @default.
• W2890174389 hasRelatedWork W2005121106 @default.
• W2890174389 hasRelatedWork W2007354208 @default.
• W2890174389 hasRelatedWork W2069108494 @default.
• W2890174389 hasRelatedWork W2070510681 @default.
• W2890174389 hasRelatedWork W2270387952 @default.
• W2890174389 hasRelatedWork W2331785319 @default.
• W2890174389 hasRelatedWork W2333609506 @default.
• W2890174389 hasRelatedWork W2406268472 @default.
• W2890174389 hasRelatedWork W2411751583 @default.
• W2890174389 hasRelatedWork W2418031874 @default.
• W2890174389 hasRelatedWork W2511639743 @default.
• W2890174389 hasRelatedWork W2603594152 @default.
• W2890174389 hasRelatedWork W2753700697 @default.
• W2890174389 hasRelatedWork W2954381926 @default.
• W2890174389 hasRelatedWork W2963939534 @default.
• W2890174389 hasRelatedWork W3005912781 @default.
• W2890174389 hasRelatedWork W2182273821 @default.
• W2890174389 isParatext "false" @default.
• W2890174389 isRetracted "false" @default.
• W2890174389 magId "2890174389" @default.
• W2890174389 workType "article" @default.